<DOC>
	<DOCNO>NCT00725582</DOCNO>
	<brief_summary>The purpose study evaluate effect IMA-026 , antibody IL-13 , airway hyperresponsiveness airway inflammation mild asthmatic . IMA-026 give 2 injection skin 1 week apart 2 mg/kg dose . The study include screen period treatment period include dos day 1 day 8 .</brief_summary>
	<brief_title>Study Evaluating Effect IMA-026 Allergen-Induced Late Asthma Response Mild Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>1 . Healthy men woman 18 60 yr mild allergic asthma 2. asthma med shortacting bronchodilator use twice weekly 3 . FEV1 great 70 % predict demonstrated baseline late response allergen induction 1 . Upper respiratory infection asthma exacerbation 4 week screen 2 . Serious infection require parenteral antibiotic hospitalization 4 week test article administration 3 . Positive radiographic finding indicative respiratory disease asthma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2009</verification_date>
</DOC>